European Journal of Epidemiology

, Volume 11, Issue 6, pp 655–660

Seroepidemiology of rickettsial infections in Morocco

Article

Abstract

The prevalence of antibodies reactive withRickettsia conorii, Rickettsia typhi, Coxiella burnetii andEhrlichia chaffeensis was investigated using indirect immunofluorescence (IFA) test on human sera obtained from 300 blood donors in Casablanca and 126 sera obtained from clinical laboratories in Fez. In sera from Casablanca, antibodies reactive at titers >=1: 32 were found againstR. conorii (7%), andR. typhi (1.7%), but not againstE. chaffeensis. In the sera from Fez, antibodies were also detected againstR. conorii (5.6%),R. typhi (4%), but not againstE. chaffeensis. By Western immunoblotting, seroprevalence forR. conorii was in Casablanca and 4.8% in Fez. Antibodies reactive at titers >=1:50 againstC. burnetii (phase II) were present in sera from Casablanca (1%) and Fez (18.3%).

Key words

Coxiella burnetii Ehrlichia chaffeensis Rickettsia conorii Rickettsia typhi Seroepidemiology Morocco 

Abbreviations

IFA

Immunofluorescence assay

MSF

Mediterranean spotted fever

PBS

Phosphate-buffered saline

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    WHO. Global surveillance of rickettsial diseases: Memorandum from a WHO meeting. Bull WHO 1993; 71: 293–296.Google Scholar
  2. 2.
    Conor A, Bruch A. Une fièvre éruptive observée en Tunisie. Bull Soc Path Exot 1910; 8: 492–496.Google Scholar
  3. 3.
    Conor A, Hayat A. Nouveaux faits concernant la fièvre boutonneuse de Tunisie. Bull Soc Path Exot 1910; 10: 759–764.Google Scholar
  4. 4.
    Olmer D, Olmer J. Epidémie des rickettsioses sur le littoral méditerran éen: La fièvre boutonneuse. Rev Pathol Gen Comp 1957; 80–92.Google Scholar
  5. 5.
    Weiss E, Moulder JW. Order I. Rickettsiales Gieszczkiewicz 1939, 25AL. In: Kreig NR, Holt JG (eds), Bergey's manual of systematic bacteriology. Baltimore: Williams & Wilkins, 1984: 687–704.Google Scholar
  6. 6.
    Raoult D, Weiller PJ, Chagnon A, et al. Mediterranean spotted fever: Clinical, laboratory and epidemiological features of 199 cases. Am J Trop Med Hyg 1986; 35: 845–850.Google Scholar
  7. 7.
    Raoult D, Etienne J, Massip P, et al. Q fever endocarditis in the South of France. J Infect Dis 1987; 155: 570–573.Google Scholar
  8. 8.
    Babudieri B. Q fever: A zoonosis. Adv Veter Sc 1954; 10: 81–182.Google Scholar
  9. 9.
    Gutfreund R, Gelberg V, Chabaud MA. Enquðe préliminaire sur la fièvre Q en Ethiopie. Bull Soc Path Exot 1955; 451–453.Google Scholar
  10. 10.
    Raoult D. La fièvre Q: Infection aCoxiella burnetii. Encycl Med Chir (Paris, France), Maladies infectieuses 1988; 8077 (10): 1–10.Google Scholar
  11. 11.
    Dawson JE, Anderson BE, Fishbein DB, et al. Isolation and characterization of anEhrlichia sp. from a patient diagnosed with human ehrlichiosis. J Clin Microbiol 1991; 29: 2741–2745.Google Scholar
  12. 12.
    Anderson BE, Sims KG, Olson JG, et al.Amblyomma americanum: A potential vector of human ehrlichiosis. Am J Trop Med Hyg 1993; 49: 239–244.Google Scholar
  13. 13.
    Brouqui P, Raoult D. In vitro antibiotic susceptibility of the newly recognized agent of ehrlichiosis in humans,Ehrlichia chaffeensis. Antimicrob Agents Chemother 1992; 36: 2799–2803.Google Scholar
  14. 14.
    Giménez DF. Staining rickettsiae in yolk-sac cultures. Stain Technol 1964; 39: 135–140.Google Scholar
  15. 15.
    Weiss E, Coolbaugh JC, Williams JC. Separation of viableRickettsia typhi from yolk-sac and L cell host components by renografin density gradient centrifugation. Appl Microbiol 1975; 30: 456–463.Google Scholar
  16. 16.
    Babalis T, Tissot Dupont H, Tselentis Y, et al.Rickettsia conorii in Greece: Comparison of a microimmunofluorescence assay and western blotting for seroepidemiology. Am J Trop Med Hyg 1993; 48: 784–792.Google Scholar
  17. 17.
    Tissot Dupont H, Raoult D, Brouqui P, et al. The epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. Am J Med 1992; 93: 427–434.Google Scholar
  18. 18.
    Laemmli UK. Clivage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685.Google Scholar
  19. 19.
    Towbin A, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350–4354.Google Scholar
  20. 20.
    Raoult D, Dasch GA. Line blot and Western blot immunoassays for diagnosis of Mediterranean spotted fever. J Clin Microbiol 1989; 27: 2073–2079.Google Scholar
  21. 21.
    Tissot Dupont H, Thirion X, Raoult D. Q fever serology: Cutoff determination for microimmunofluorescence. Clin Diagn Lab Immunol 1994; 1: 189–196.Google Scholar
  22. 22.
    Benhamou E, Destaing, Ferrand, et al. Premiers succès de l;aureomycine dans les rickettsioses nordafricaines. Sem Hop Paris 1949; 84: 3495–3498.Google Scholar
  23. 23.
    Benhammou B, Balafrej A, Mikou N. Fièvre boutonneuse m éditerranéenne révélée par une atteinte neurologique grave. Arch Fr Pediatr 1991; 48: 635–636.Google Scholar
  24. 24.
    Belmejdoub G. Les rickettsioses au Maroc [Thesis, Medicine]. Rabat, Morocco: Université Mohammed V, 1987, 137 p.Google Scholar
  25. 25.
    Schlaeffer F, Lederer K, Mates SM. Mediterranean spotted fever in an American women. Arch Intern Med 1985; 145: 1733–1734.Google Scholar
  26. 26.
    Blanc G.Rickettsia (Coxiella) burnetii (Derrick) au Maroc et accessoirement en Algérie et en Afrique équatoriale: Etude expérimentale. Rev Beige Pathol Med Exptl 1951; 21: 17–36.Google Scholar
  27. 27.
    Blanc G, Bruneau J. Un réservoir du virus de la 'Q fever' en Algérie, la tique bovineHyalomma mauritanicum. Bull Acad Natl Med (Paris) 1949; 133: 115–117.Google Scholar
  28. 28.
    Blanc G, Martin LA, Maurica A. Présence du virus de la 'Q fever' dans le Maroc méridional. Bull Acad Natl Med (Paris) 1947; 131: 138–143.Google Scholar
  29. 29.
    Garin JP. La fiévre Q dans le bassin méditerranéen: Enquête épid émiologique au Maroc (Tafilalet). Rev Lyonn Med 1953; 2: 239–245.Google Scholar
  30. 30.
    Weil E, Felix A. Zur serologischen Diagnose des Fleckfiebers. Wien Klin Wochenschrift 1916; 29: 33–35.Google Scholar
  31. 31.
    Plotz H, Reagan RL, Wertman K. Differentiation between ‘fièvre boutonneuse’ and Rocky Mountain spotted fever by means of complement fixation. Proc Soc Exp Biol Med 1944; 55: 173–176.Google Scholar
  32. 32.
    Giroud P. Agglutination des rickettsies. Bull Soc Path Exot 1944; 37: 84–93.Google Scholar
  33. 33.
    Newhouse VF, Shepard CC, Redus MA, et al. A comparison of the complement fixation, indirect fluorescent antibody, and microagglutination tests for the serological diagnosis of rickettsial diseases. Am J Trop Med Hyg 1979; 28: 387–395.Google Scholar
  34. 34.
    Beati L, Teysseire N, Raoult D. Kinetics of specific antibodies in Mediterranean spotted fever determined by western blotting and microimmunofluorescence. Acta virol 1992; 36: 62–66.Google Scholar
  35. 35.
    Espejo-Arenas E, Font-Creus B, Alegre-Segura MD, et al. Seroepidemiological survey of Mediterranean spotted fever in an endemic area (‘Vallés occidental’, Barcelona, Spain). Trop Geogr Med 1990; 42: 212–216.Google Scholar
  36. 36.
    Mansueto S, Vitale G, Miceli MD, et al. A seroepidemiological survey of asymptomatic cases of boutonneuse fever in western Sicily. Trans R Soc Trop Med Hyg 1984; 78: 16–18.Google Scholar
  37. 37.
    Raoult D, Tissot Dupont H, Chicheportiche C, et al. Mediterranean spotted fever in Marseille, France: Correlation between prevalence of hospitalized patients, seroepidemiology, and prevalence of infected ticks in three different areas. Am J Trop Med Hyg 1993; 48: 249–256.Google Scholar
  38. 38.
    Rauolt D, Toga B, Chaudet H, et al. Rickettsial antibodies toRickettsia conorii and Coxiella burneti among urban, suburban and semirural blood donors. Trans R Soc Trop Med Hyg 1987; 80–81.Google Scholar
  39. 39.
    Radulovic S, Walker DH, Weiss K, et al. Prevalence of antibodies to spotted fever group rickettsiae along the Eastern coast of the Adriatic Sea. J Clin Microbiol 1993; 31: 2225–2227.Google Scholar
  40. 40.
    Tissot Dupont H, Brouqui P, Faugère B, et al. Seroprevalence of rickettsioses in Africa. Clin Infect Dis 1995; (in press).Google Scholar
  41. 41.
    Kelly PJ, Mason PR, Matthewman LA, et al. Seroepidemiology of spotted fever group rickettsial infections in humans in Zimbabwe. J Trop Med Hyg 1991; 94: 304–309.Google Scholar
  42. 42.
    Kelly PJ, Matthewman LA, Beati L, et al. African tick-bite fever: A new spotted fever group rickettsiosis under an old name. Lancet 1992; 340: 982–983.Google Scholar
  43. 43.
    Brouqui P, Delmont J, Raoult D, et al. Etat actuel des connaissances sur l'épidémiologie des rickettsioses en Afrique. Bull Soc Path Exot 1992; 85: 1–6.Google Scholar
  44. 44.
    Brouqui P, Le Cam C, Kelly PJ, et al. Serologic evidence for human ehrlichiosis in Africa. Eur J Epidemiol 1994; 10: 695–698.Google Scholar

Copyright information

© Kluwer Academic Publishers 1995

Authors and Affiliations

  • M. Meskini
    • 1
  • L. Beati
    • 1
  • A. Benslimane
    • 2
  • D. Raoult
    • 1
  1. 1.Unité des RickettsiesFaculté de MédecineMarseilleFrance
  2. 2.Institut Pasteur du MarocCasablancaMaroc

Personalised recommendations